Hospira stock could surge with successful inspection of facility, Barron's says Hospira's (HSP) Rocky Mount drug manufacturing facility could be inspected by the FDA in the first half of this year. If the facility passes the inspection, it would increase the company's production and allow the company to expand into other markets, according to Barron's. Reference Link
News For HSP From The Last 14 Days
Check below for free stories on HSP the last two weeks.